Clinical study to evaluate the efficacy of blood purification therapy on cholesterol crystal embolism
- Conditions
- cholesterol crystal embolism
- Registration Number
- JPRN-UMIN000009306
- Lead Sponsor
- Incorporated administrative agency, Japan Community Health care Organization, Sendai Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 35
Not provided
Patients who meet any of the following criteria will be excluded. (i) Patients with contraindication to anticoagulant (Nafamostat Mesilate). (ii) Blood purification therapy is inapplicable because of severe heart failure, acute myocardial infarction, severe arrhythmia, acute stroke, or severe uncontrollable hypertension or hypotension. (iii) Patients with body weight less than 40kg. (iv) Patients with a history of allergic reaction or hypersensitivity to blood purification therapy. (v) Patients who cannot stop taking ACE inhibitors. (vi) Patients with any disease in which corticosteroid, statin are contraindicated. (vii) Patients participated in another clinical trial or study at the time of obtaining informed consent. (viii) Patients receiving chronic hemodialysis. (ix) Otherwise, patients who are judged by the investigator as being unsuitable for inclusion in the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method